Razumab 10mg Injection contains Ranibizumab, which is primarily used in the treatment of certain retinal diseases.   

Brand Name: Razumab

Composition: Ranibizumab

Mechanism of Action:

An anti-VEGF drug called ranibizumab attaches itself to VEGF-A, a protein involved in angiogenesis, the development of new blood vessels, and suppresses it. Ranibizumab helps patients with certain retinal illnesses retain or enhance their vision by blocking VEGF-A, which also lessens the growth of aberrant blood vessels and the leakage from these vessels.

Uses:

• Neovascular (wet) age-related macular degeneration
• Diabetic macular edema
• Macular edema following retinal vein occlusion
• Myopic choroidal neovascularization

Dosage and Administration:

Usually given once a month (every 28 days) as a single intravitreal injection of 0.5 mg (0.05 mL). The particular disease and the patient's reaction determine the precise dosage and frequency. administered by a trained ophthalmologist straight into the eye's vitreous cavity.

Side Effects:

• Nausea
• Vomiting
• Fever
• Headache
• Dizziness
• Swelling
• Diarrhea

Safety Advise:

Liver  

Patients with hepatic impairment may require dose modifications. Throughout treatment, liver function should be routinely assessed. Kindly speak with your healthcare provider.

Kidney  

Patients with renal impairment may require dose modifications. Throughout treatment, kidney function should be routinely assessed. Kindly speak with your healthcare provider.

Pregnancy  

As Ranibizumab may harm the fetus, it is not advised to use it during pregnancy. Kindly speak with your healthcare provider.

Breast Feeding  

Razumab 10mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Kindly speak with your healthcare provider.

Alcohol    

Drinking alcohol while taking Razumab 10mg Injection is not advised. Kindly speak with your healthcare provider.

Storage:

Store the vial at 2°C to 8°C (36°F to 46°F) in a refrigerator. Do not freeze. Protect from light.

How to use this Medication?

Products for ranibizumab injections are available as a liquid solution that a physician can inject into the eye. It is typically administered once a month in a doctor's office. If it is more convenient for you, your doctor may provide your injections at a different time.

 

Additionally, ranibizumab is available as an implant that a physician can place with a needle in a clinic or doctor's office into the white portion of your eye. Every six months, a doctor in a clinic or medical office will need to refill the implant by injecting more fluid into it.

References:

1. Blick SK, Keating GM, Wagstaff AJ. Ranibizumab. Drugs. 2007 Jun;67:1199-206.

2. Narayanan R, Kuppermann BD, Jones C, Kirkpatrick P. Ranibizumab. Nature Reviews Drug Discovery. 2006 Oct 1;5(10).

3. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology. 2007 Dec 1;114(12):2179-82.

4. Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. American journal of ophthalmology. 2007 Apr 1;143(4):679-80.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Intas Pharmaceuticals Ltd

Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Country of origin: India